Compound information
- Natural Products
- ZC1635489
- Molecular Formula
- C16H23BrN2O4S
- Molecular Weight
- 418.056190316 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(3-bromo-4-methyl-phenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C16H23BrN2O4S/c1-12-5-6-13(11-14(12)17)24(21,22)19-9-7-18(8-10-19)15(20)23-16(2,3)4/h5-6,11H,7-10H2,1-4H3
- InChI Key
- FZSFGOWSJGUTOY-UHFFFAOYSA-N
- SMILES
- Cc1ccc(S(=O)(=O)N2CCN(C(=O)OC(C)(C)C)CC2)cc1Br
- Source
- ZINC000514269722
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 3.465 |
LogS | -4.854 | LogD | 3.919 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.118 | Pgp substrate | 0.012 |
HIA | 0.968 | F20 % | 0.992 |
F30 % | 0.971 | Caco-2 | -4.547 |
MDCK | -4.792 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.867 | PPB | 98.077 |
VD | 2.617 | Fu | 0.791 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.153 | CYP1A2 substrate | 0.503 |
CYP2A6 substrate | 0.656 | CYP2B6 substrate | 0.683 |
CYP2C19 inhibitor | 0.968 | CYP2C19 substrate | 0.793 |
CYP2C8 substrate | 0.684 | CYP2C9 inhibitor | 0.737 |
CYP2C9 substrate | 0.999 | CYP2D6 inhibitor | 0.06 |
CYP2D6 substrate | 0.714 | CYP2E1 substrate | 0.813 |
CYP3A4 inhibitor | 0.342 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.288 | CL | 6.298 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.865 | Hepatotoxicity | 0.997 |
Mutagenicity | 0.608 | Rat Oral Acute Toxicity | 0.157 |
FDAMDD | 0.107 | Skin Sensitization | 0.009 |
Carcinogenicity | 0.951 | Eye Corrosion | 0.025 |
Eye Irritation | 0.067 | Respiratory Toxicity | 0.656 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.637 | IGC50 | 4.219 |
LC50FM | 2.852 | LC50DM | 4.028 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.238 | NR-AR-LBD | 0.284 |
NR-AhR | 0.026 | NR-Aromatase | 0.549 |
NR-ER | 0.246 | NR-ER-LBD | 0.398 |
NR-PPAR-gamma | 0.127 | SR-ARE | 0.698 |
SR-ATAD5 | 0.37 | SR-HSE | 0.094 |
SR-MMP | 0.027 | SR-p53 | 0.032 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.